Tomas Kiselak, Director: Dianthus Therapeutics DNTH Buy · Filed 23/09/21

Trade details

Type: Insider buy
Amount: $396,000
Shares · price: 30,000 sh · $13.20 a share
Held after: 1,873,833 sh
Stock: Dianthus Therapeutics DNTH
Person: Tomas KiselakDirector
Trade date: 23/09/19
Filed: 23/09/21
Days to filing: 2 days

4 insiders bought this week

Insiders buying this week: 4 insiders
Holding change: +1.6%

Dianthus Therapeutics trades, last 26 weeks

What else happened in Dianthus Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/20~23/10/19

Tomas Kiselak's recent trades

Tomas KiselakDirector
SellSpyre Therapeutics
Sell
Spyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
Tomas KiselakDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31
Tomas KiselakDirector
SellApogee Therapeutics
Sell
Apogee Therapeutics
APGE
$133.5M
1,750,000 sh
$133.5M
Filed 01/22
Traded 01/22
Tomas KiselakDirector
BuyCrescent Biopharma
Buy
Crescent Biopharma
CBIO
$18.2M
1,360,000 sh
$18.2M
Filed 25/12/08
Traded 25/12/04
Tomas KiselakDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$6M
316,219 sh
$6M
Filed 25/10/09
Traded 25/10/07